Screening for liver fibrosis in the general population: where do we stand in 2022?

HIGHLIGHTS

  • who: Clu00e9mence M. Canivet and Ju00e9ru00f4me Boursier from the , Angers, France have published the research work: Screening for Liver Fibrosis in the General Population: Where Do We Stand in 2022?, in the Journal: Diagnostics 2023, 13, 91. of /2023/
  • what: In this review, the authors aim to present the current state of screening for advanced liver fibrosis.

SUMMARY

    Liver fibrosis is the main prognostic factor in chronic liver diseases and longitudinal studies have shown that patient morbidity and mortality were significantly increased in patients with advanced liver fibrosis, i.e., septal . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?